BRONCHO-VAXOM ADULTI 7 mg România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

broncho-vaxom adulti 7 mg

flavine pharma france - franta - biologic (lysatum bacteriale om 85 cryodesicatum) - caps. - 7mg - alte vaccinuri vaccinuri

BRONCHO-VAXOM COPII 3,5 mg România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

broncho-vaxom copii 3,5 mg

flavine pharma france - franta - biologic (lysatum bacteriale om 85 cryodesicatum) - caps. - 3.5mg - alte vaccinuri vaccinuri

BRONCHO-VAXOM COPII 3,5 mg România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

broncho-vaxom copii 3,5 mg

flavine pharma france - franta - biologic (lysatum bacteriale om 85 cryodesicatum) - pulb. pt. susp. orala - 3,5mg - alte vaccinuri vaccinuri

URO - VAXOM România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

uro - vaxom

flavine pharma france - franta - diverse - caps. - 6mg - alte vaccinuri vaccinuri

DOXIPROCT 40 mg+20 mg/g România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

doxiproct 40 mg+20 mg/g

flavine pharma france - franta - combinatii (calcii dobesilas+lidocainum) - unguent rectal - 40mg+20mg/g - antihemoroidale topice preparate continind anestezice locale

DOXIPROCT PLUS 40 mg+20 mg+0,25 mg/g România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

doxiproct plus 40 mg+20 mg+0,25 mg/g

flavine pharma france - franta - combinatii (calcii dobesilas+lidocainum+dexamethasonum) - unguent rectal - 40mg+20mg+0,25mg/g - antihemoroidale pentru utilizare locala preparate continind corticosteroizi

DOXIUM 500 România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

doxium 500

om pharma s.a. - portugalia - calciu dobesilas - caps. - 500mg - medicatia antivaricoasa alte medicamente sclerozante

Vildagliptin / Metformin hydrochloride Accord Uniunea Europeană - română - EMA (European Medicines Agency)

vildagliptin / metformin hydrochloride accord

accord healthcare s.l.u. - metformin hydrochloride, vildagliptin - diabetul zaharat, tip 2 - medicamente utilizate în diabet - vildagliptin/metformin hydrochloride accord is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:- in patients who are inadequately controlled with metformin hydrochloride alone. - in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. - in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4. 4, 4. 5 și 5. 1 pentru datele disponibile pe diferite combinații).

Icandra (previously Vildagliptin / metformin hydrochloride Novartis) Uniunea Europeană - română - EMA (European Medicines Agency)

icandra (previously vildagliptin / metformin hydrochloride novartis)

novartis europharm limited - vildagliptin, clorhidrat de metformină - diabetul zaharat, tip 2 - drugs used in diabetes, combinations of oral blood glucose lowering drugs - icandra is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:in patients who are inadequately controlled with metformin hydrochloride alone. in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4. 4, 4. 5 și 5. 1 pentru datele disponibile pe diferite combinații).

Zomarist Uniunea Europeană - română - EMA (European Medicines Agency)

zomarist

novartis europharm limited  - vildagliptin, clorhidrat de metformină - diabetul zaharat, tip 2 - medicamente utilizate în diabet - zomarist is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:in patients who are inadequately controlled with metformin hydrochloride alone. in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate.